Milan Kalawadia
Milan Kalawadia is the Chief Executive Officer, North America at Dr. Reddy’s Laboratories Inc. He is responsible for leading the North America business and serves as a member of the Board of Dr. Reddy’s Laboratories, Inc. Milan has more than 19 years of experience in the pharmaceutical marketplace. He has been with Dr. Reddy’s since 2006. […]
Sumit Jain
Sumit Jain is the Chief Executive Officer of Torrent Pharma Inc., the U.S. subsidiary of Torrent Pharma Limited. He is responsible for the business operations of all Torrent entities in the U.S. Sumit has over 20 years of experience in the pharmaceutical marketplace. Prior to joining Torrent, he was the Vice President of Strategy, Analytics […]
Pamela Hoffman
Pamela Hoffman is the President of Padagis. She is a seasoned professional with extensive experience in the pharmaceutical industry. Pamela has built a career driving operational excellence and financial stewardship in the generic and OTC medicines sector. Prior to leading Padagis she spent over 15 years with Perrigo Company and Stryker in various leadership roles. Her […]
Bob Hoffman (Chair)
Bob Hoffman is AAM Board Chair and Chief Commercial Officer of US Generics for Lupin Pharmaceuticals, Inc. In this role, he is responsible for executing the strategic direction of the business and all of the Commercial Operations functions. He has been with Lupin since 2005 and has over 31 years of experience in the pharmaceutical […]
Keren Haruvi
Keren Haruvi is President of Sandoz North America. In her role at Sandoz, she leads Sandoz’s largest commercial and country organization – the United States – which is responsible for approximately a quarter of the global revenue for Sandoz Inc. She also oversees Sandoz commercial operations in Canada, and is a member of the Global […]
Gretchen Fritz
Gretchen Fritz has been at American Regent since 2006 and is responsible for overseeing all legal and IP matters for American Regent, Inc. Prior to becoming Chief Legal Officer, Gretchen served in a number of legal positions across the Daiichi Sankyo Group in both the U.S. and Japan. Before joining the Daiichi Sankyo Group, Gretchen […]
Kevin Fortier
Kevin Fortier is the Chief Commercial Officer at Jubilant Cadista Pharmaceuticals, Inc. Kevin joined Cadista in April of 2014 as a National Account Director and has held roles of increasing responsibility during the past nine years. Kevin’s experience includes working for a wholesaler (Value Drug); a contract services company (now IQVIA); a retail pharmacy chain […]
Marc Falkin
Marc Falkin is the Chief Executive Officer for Cipla North America and is also a member of Cipla’s Management Council. He is based out of New Jersey and is responsible for leading Cipla’s ambitious plans in North America. Prior to being named the CEO in July 2024, he served as Cipla’s Chief Commercial Officer in North […]
Matthew Erick
Matthew Erick is the Chief Commercial Officer – Advanced Markets and is based in the U.S. Matt, who joined Biocon Biologics in 2022, is responsible for driving the commercial strategy and sales for Biocon Biologics in the advanced markets of North America, Europe, Japan, Australia and New Zealand. Matt will be working closely with partners […]
Dan Dischner
Dan Dischner serves as the Senior Vice President, Human Resources and Corporate Communications, at Amphastar Pharmaceuticals, Inc. Dan oversees all aspects of Amphastar’s communications efforts, including internal and external global communications, public relations, government affairs and corporate community responsibility. Additionally, in his role within Human Resources, Dan leads in the growth and professional development of employees […]
Victoria Wohlfeil Cherry
Victoria Wohlfeil Cherry is Meitheal’s General Counsel & Corporate Secretary since its inception in 2017. In addition, Victoria is the Corporate Secretary of Xentria, Inc. a biotech company focused on novel biologics and biosimilars, which was established in April 2020. Victoria came to Meitheal from Sagent Pharmaceuticals where she most recently served as Associate General Counsel and […]
Jeff Burd (Treasurer)
Jeff Burd is AAM Board Treasurer and President & CEO, North America, of Ajanta Pharma USA Inc., where he is responsible for the company’s strategy and all commercial operations in the United States. He has worked at Ajanta Pharma since 2013 and has more than 20 years of experience across the pharmaceutical industry. Prior to […]
